Orthofix Medical/$OFIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orthofix Medical
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
Ticker
$OFIX
Sector
Primary listing
Employees
1,616
Headquarters
Website
Orthofix Medical Metrics
BasicAdvanced
$584M
-
-$3.18
0.89
-
Price and volume
Market cap
$584M
Beta
0.89
52-week high
$20.48
52-week low
$10.24
Average daily volume
308K
Financial strength
Current ratio
2.668
Quick ratio
1.315
Long term debt to equity
38.071
Total debt to equity
38.244
Interest coverage (TTM)
-3.31%
Profitability
EBITDA (TTM)
15.984
Gross margin (TTM)
68.88%
Net profit margin (TTM)
-15.29%
Operating margin (TTM)
-11.68%
Effective tax rate (TTM)
-0.82%
Revenue per employee (TTM)
$500,000
Management effectiveness
Return on assets (TTM)
-5.95%
Return on equity (TTM)
-24.63%
Valuation
Price to revenue (TTM)
0.711
Price to book
1.27
Price to tangible book (TTM)
3.16
Price to free cash flow (TTM)
1,247.996
Free cash flow yield (TTM)
0.08%
Free cash flow per share (TTM)
0.012
Growth
Revenue change (TTM)
4.84%
Earnings per share change (TTM)
-1.03%
3-year revenue growth (CAGR)
20.54%
10-year revenue growth (CAGR)
7.51%
3-year earnings per share growth (CAGR)
19.49%
10-year earnings per share growth (CAGR)
19.31%
What the Analysts think about Orthofix Medical
Analyst ratings (Buy, Hold, Sell) for Orthofix Medical stock.
Bulls say / Bears say
Pro forma net sales were up 4% year-over-year on a constant currency basis to $200.7 million in Q2 2025, showing consistent revenue strength despite macroeconomic uncertainty.
U.S. Orthopedics net sales jumped 28% year-over-year in Q2 2025, indicating strong commercial performance and growing market share in U.S. orthopedics.
The company posted positive free cash flow of $4.5 million in Q2 2025—a strong improvement from a $107.8 million negative free cash flow for full-year 2023, highlighting better working capital management and operational control.
Continued operating loss of $16.0 million in Q2 2025 shows the business is still not profitable at its core.
Ending the M6® artificial disc product lines cut Q2 net sales by $2.5 million and is expected to bring around $10 million in related costs in 2025, creating financial pressure in the near term.
High SG&A expenses of $136.5 million used up nearly 98% of gross profit for Q2 2025, leaving little room for the company to turn revenue growth into sustainable operating profits.
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
Orthofix Medical Financial Performance
Revenues and expenses
Orthofix Medical Earnings Performance
Company profitability
Orthofix Medical News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Orthofix Medical stock?
Orthofix Medical (OFIX) has a market cap of $584M as of October 15, 2025.
What is the P/E ratio for Orthofix Medical stock?
The price to earnings (P/E) ratio for Orthofix Medical (OFIX) stock is 0 as of October 15, 2025.
Does Orthofix Medical stock pay dividends?
No, Orthofix Medical (OFIX) stock does not pay dividends to its shareholders as of October 15, 2025.
When is the next Orthofix Medical dividend payment date?
Orthofix Medical (OFIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Orthofix Medical?
Orthofix Medical (OFIX) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.